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ABSTRACT
Ameloblastoma, the most clinically significant odontogenic epithelial tumor, is a locally-invasive and destructive lesion in 
the jawbones. However, the nature of this infiltrativeness and destructive behavior remains ill-understood. To address this, 
we established an in vitro three-dimensional (3D) co-culture system to simulate an amelobastoma disease model aimed at 
investigating the interactions between tumor cells and osteoblasts. Osteoblastic cell lines (KUSA/A1 and MC3T3-E1) and 
one stromal cell line (ST2) were separately co-seeded with ameloblastoma-derived cell line (AM-1) in a collagen scaffold 
(representing the extracellular bone matrix) and incubated with mineralization medium. Immunohistochemistry, double 
immunofluorescence and mineralization assay were performed. Only AM-1/KUSA-A1 co-culture showed a significant 
increase in AM-1 cell count, suggesting that heterotypic cell-cell interaction promotes tumoral cell growth, while 
formation of visible AM-1 epithelial nest-like structures resembling ameloblastoma cells in their native state, suggest 
morphodifferentiation. A RANK-high, RANKL-low and osteoprotegerin-low immunoprofile in co-culture AM-1 cells implies 
deregulated osteoclastogenesis. Mineralization assays showed diminished calcification in AM-1/KUSA-A1 co-culture 
extracellular matrix suggesting an altered local bone metabolism. In contrast, KUSA/A1 monocultures showed abundant 
extracellular matrix calcification. Taken together, these results suggest that a 3D co-culture system as an amelobastoma 
disease model provides insights that bidirectional ameloblastoma-osteoblastic interactions might play a role in modulating 
tumor growth and osteoclastogenesis.
Keywords: Ameloblast; ameloblastoma modelling; co-culture system; pre-osteoblast
ABSTRAK
Ameloblastoma, tumor epitelium odontogenik yang paling umum secara klinikal, ialah lesi invasif setempat dan lesi 
memusnah yang didapati di tulang rahang. Walau bagaimanapun, sifat penyusupan dan perilaku yang merosakkan masih 
tidak difahami. Untuk menangani ini, kami menubuhkan satu sistem in vitro tiga dimensi (3D) untuk mensimulasikan model 
penyakit amelobastoma, bertujuan untuk mengkaji interaksi antara tumor dan sel osteoblastik. Sel-sel osteoblastik (KUSA/
A1 dan MC3T3-E1) dan satu sel stromal (ST2) bersandarkan dengan sel-sel tumor ameloblastoma, AM-1 secara berasingan 
dalam gel kolagen (mewakili matriks tulang ekstrasel) dan diinkubasi dengan medium  pemineralan.  Imunohistokimia, 
imunopendarfluor ganda dua dan asai mineral dijalankan. Hanya kultivar AM-1/KUSA-A1 menunjukkan kenaikan ketara 
dalam jumlah sel AM-1, menunjukkan bahawa interaksi sel heterotip menggalakkan pertumbuhan sel tumor, manakala 
pembentukan struktur seperti sarang epitelium AM-1 kelihatan sebagai sel ameloblastoma dalam keadaan asalnya, 
mencadangkan pembezaan morfotip. RANK-Tinggi, RANKL-rendah dan osteoprotegerin-rendah imunoprofil dalam ko-kultur 
dengan sel AM-1 mencadangkan osteoklastogenesis yang tidak terkawal. Pemineralan asai juga menunjukkan bahawa 
kalsifikasi dalam matriks ekstrasel AM-1/KUSA-A1 telah mencadangkan perubahan dalam metabolisme tulang setempat. 
Sebaliknya, monokultur KUSA/A1 menunjukkan kalsifikasi matriks ekstrasel yang signifikan. Secara eksplisit, keputusan 
ini menunjukkan bahawa sistem ko-kultur 3D sebagai model penyakit amelobastoma memberikan pandangan terperinci 
terhadap interaksi antara ameloblastoma dan osteoblas dan keupayaannya untuk memainkan peranan penting dalam 
pengubahan pertumbuhan tumor dan osteoklastogenesis.
Kata kunci: Ameloblas; pemodelan ameloblastoma; pra-osteoblas; sistem ko-kultur
INTRODUCTION
Ameloblastoma, the most common and clinically 
significant odontogenic epithelial neoplasm, accounts for 
approximately 11% to 18% of all odontogenic tumors 
(Ringer & Kolokythas 2017; Vered et al. 2017; Wright & 
Vered 2017). Although clinically benign, it is characterized 
by a locally-invasive and osseo-destructive behavior and 
a high rate of recurrence (Vered et al. 2017). According 
to the 2017 World Health Organization Classification of 
Head and Neck Tumors, four categories were classified: 
conventional, extraosseous/peripheral, unicystic, and 
metastasizing ameloblastoma (Vered et al. 2017; Wright 
& Vered 2017). In cancers, recent research efforts have 
increasingly focused on in vitro 3D models including 
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metastatic bone models to better understand tumor-stromal 
interactions (Fong et al. 2016; Kim & Othmer 2013; Liu 
et al. 2016; Luis-Ravelo et al. 2011;Wendler et al. 2016). 
Less appreciated are parenchyma-osteoblast interactions 
and their potential role in regulating tumoral growth and 
local invasiveness in ameloblastoma. In the present study, 
we constructed an in vitro 3D co-culture system to simulate 
an ameloblastoma disease model aimed at elucidating the 
effects of heterotypic cell-cell interactions on tumoral 
growth and bone turnover. The rationale was to gain some 
insights into the cellular dynamics of this neoplasm.
MATERIALS AND METHODS
MONOLAYER 2D CELL CULTURE
The ameloblastoma cell line, AM-1 was established by 
Dr. Hidemitsu Harada from Iwate Medical University, 
Japan. A mouse pre-osteoblastic cell line, KUSA/A1 was 
courtesy of Dr. Akihiro Umezawa from Keio University, 
Tokyo, Japan. The stromal cell line ST2, derived from 
mouse bone marrow and the immortalized mouse 
osteoblastic cell line, MC3T3-E1 were obtained from 
RIKEN BRC (Tsukuba, Japan). AM-1 cells were cultured in 
keratinocyte-serum free medium (K-SFM) supplemented 
with 1 ng/mL recombinant epithelial growth factor (EGF) 
and 50 μg/mL bovine pituitary extract (BPE) (all from 
GIBCO, El Paso, TX, USA). KUSA/A1, ST2 and MC3T3-E1 
cells were cultured in Minimal Essential Alpha Medium 
(α-MEM, GIBCO, USA) supplemented with 10% fetal bovine 
serum (GIBCO, Burlington, ON, Canada) and 1% antibiotic-
antimycotic (GIBCO, USA). Cells were seeded on 100 mm 
culture dishes (Sigma-Aldrich, St. Louis, MO, USA) and 
incubated at 37ºC in humid air with 5% CO2. The cell 
culture medium was changed every 3 days until the cells 
were nearly confluent and passage using 0.05% trypsin-
ethylenediaminetetraacetic acid (EDTA) (GIBCO, Canada).
GROWTH OF 3D in vitro MODEL
Atelocollagen, Eagle’s MEM (Koken, Tokyo, Japan) gels 
formed the basis of 3D cellularized models. In vitro 3D 
culture of single cell types: KUSA/A1, ST2, MC3T3-E1 and 
AM-1 were prepared by harvesting cells from confluent 
monolayer cultures using 0.05% trypsin-EDTA (GIBCO, 
Canada) and Accutase (Innovative Cell Technologies, 
San Diego, CA, USA). These were counted, adjusted to 
the desired cell density, and centrifuged at 1,000 g for 
1 min in a 50 mL centrifuge tube at room temperature. 
The tube was placed on ice, and the cell pellet obtained 
was re-suspended in a solution of polymerizing collagen 
which was prepared by quickly mixing 1 volume of 
atelocollagen with 1 volume of mineralization medium 
(α-MEM containing 50 μg/mL L-ascorbic acid and 5 mM 
β-glycerophosphate) (all from Sigma-Aldrich, Dorset, 
England, UK) at a density of 8.0 × 105 cells/cm3. Aliquots 
(0.5 mL) of the cold collagen mixture were dispensed into 
24-well culture plates and allowed to gel for about 90 min 
at 37ºC before the addition of mineralization medium. In 
the meantime, three variations of in vitro 3D co-culture 
were prepared by adding a total of 8.0 × 105 cells/cm3 in 
each well of a 24-well culture plate at 1:1 ratio of AM-1 
to osteoblastic (KUSA/A1 and MC3T3-E1) and fibroblastic 
(ST2) cells in a total volume of 0.5 mL of polymerizing 
collagen mixture, and allowed to gel for 90 min at 37ºC 
prior to the addition of mineralization medium. The 3D 
monocultures (AM-1, n=3; KUSA-A1, n=3; ST2, n=3; 
MTCT3-E1, n=3) and the co-culture constructs (AM-1/
KUSA-A1, n=12; AM-1/ST2, n=12; AM-1/MTCT3-E1, n=12) 
were incubated at 37ºC in humid air with 5% CO2 at the same time and the mineralization medium was changed 
every 3 days. These cell culture constructs were harvested 
and analyzed at 3, 7, and 14 days.
CELL MORPHOLOGY ANALYSIS
All specimens from monocultures of single cell types 
(AM-1, n=3; KUSA-A1, n=3; ST2, n=3; MTCT3-E1, n=3) and 
co-culture constructs (AM-1/KUSA-A1, n=12; AM-1/ST2, 
n=12; AM-1/MTCT3-E1, n=12) were fixed in 10% formalin, 
embedded in paraffin and cut into 10 μm thick sections for 
hematoxylin (Merck KGaA, Darmstadt, Germany) and 
eosin (Waldeck KG, Münster, Germany) (H&E) staining. 
Cellular morphology analysis was performed using the 
Olympus BX43 upright microscope (Olympus, Tokyo, 
Japan) equipped with a DP27 color camera (Olympus, 
Tokyo, Japan) and CellSens software (CellSens Imaging 
Software, Olympus, Tokyo, Japan). 
IMMUNOHISTOCHEMISTRY
For all specimens from monocultures (AM-1, n=3; KUSA-A1, 
n=3; ST2, n=3; MTCT3-E1, n=3) and two specimens per 
time point from co-culture constructs (AM-1/KUSA-A1, 
n=6; AM-1/ST2, n=6; AM-1/MTCT3-E1, n=6), 10 μm thick 
paraffin sections were cut and mounted on Matsunami 
adhesive slide (MAS)-coated slides (Matsunami, Tokyo, 
Japan). These were deparaffinized in series of xylene 
(Muto Pure Chemicals, Tokyo, Japan) for 15 min and 
rehydrated in graded ethanol solutions (Japan Alcohol 
Trading, Tokyo, Japan). Antigen retrieval was achieved by 
0.1% trypsin treatment (37ºC, 15 min) (GIBCO, Canada) 
for mouse monoclonal anti-cytokeratin (IS053) (Dako, 
Glostrup, Denmark; diluted 1:50) or heat treatment using 
10mM citrate buffer solution made from 1.72 g of citric 
acid (Sigma-Aldrich, Tokyo, Japan) and 13.0 g of trisodium 
citrate dihydrate (Kanto Chemical, Tokyo, Japan) (pH 6, 5 
min, 300W) for rabbit monoclonal anti-vimentin (ab92547) 
(Abcam, Cambridge, MA, USA; diluted 1:200), mouse 
monoclonal RANK (ab13918) (Abcam, diluted 1:200), 
mouse monoclonal RANKL (ab45039) (Abcam, 1:400), and 
rabbit polyclonal osteoprotegerin (OPG) (ab9986) (Abcam, 
1:100). After treatment with normal serum (Dako for 
Envision technique; and Vector Laboratories, Burlingame, 
CA, USA for avidin-biotin complexes technique), the 
sections were incubated with primary antibodies at 4ºC 
overnight. The tagging of primary antibody was achieved 
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using Envision peroxidase mouse detection reagent 
(Dako) or by the subsequent application of anti-rabbit IgG 
biotinylated antibody and avidin-biotin complexes (Rabbit 
ABC kit, Vector Laboratories, USA). The visualization of 
immunoreactivity was performed using diaminobenzidine 
(DAB)/H2O2 solution (Nacalai Tesque, Kyoto, Japan) 
and counterstained with Mayer’s hematoxylin (Merck 
KGaA). Known positive sections of oral olfactory bulb for 
cytokeratin and vimentin, central giant cell granuloma for 
RANK, RANKL and OPG were used as positive controls. For 
negative control, sections were treated as mentioned, but 
without the application of primary antibody. All control 
sections were negative.
IMMUNOHISTOCHEMICAL ANALYSIS
The digitized images were acquired using the Olympus 
BX43 upright microscope equipped with a DP27 color 
camera and CellSens software (all from Olympus). The 
protein staining and immunoreactivity for all markers in the 
mono- and co-culture constructs were visualized at 200x 
magnification. Immunostaining was scored as negative 
(–) when none of the cells were positively stained in the 
cytoplasm, membrane or nucleus; mild (+), <25% cells 
positive; moderate (++), 25-50% cells positive; and strong 
(+++), >50% cells positive.
DUAL LABEL IMMUNOFLUORESCENCE
Dual immunofluorescence staining was performed on one 
representative specimen selected from day 3 co-culture 
constructs (AM-1/KUSA-A1, n=1). Briefly, formalin-fixed 
paraffin-embedded gels were incubated with bovine serum 
albumin (DS Pharma Biomedical, Osaka, Japan) to block 
non-specific binding. Following that, slides were incubated 
with primary mouse monoclonal anti-pan cytokeratin 
(ab27988) (Abcam; diluted 1:50) and rabbit monoclonal 
anti-vimentin (ab92547) antibody at 4ºC overnight. After 
0.05 M Tris-buffered saline (TBS) washes, slides were 
incubated with goat anti-mouse IgG H&L (Alexa Fluor 
568) (ab175473) (Abcam) and goat anti-rabbit IgG H&L 
(Alexa Fluor 488) (ab150077) (Abcam) for 1 h at room 
temperature. The sections were then counterstaining with 
4’, 6-diamidino-2-phenylindole (DAPI) (Nacalai Tesque), 
nucleic acid dye, mounted and viewed under Zeiss LSM 
780 laser scanning confocal microscope (Carl Zeiss, 
Oberkochen, Germany). 
MINERALIZATION ASSAY
For analysis of mineralized nodule formation, all samples 
from the osteoblastic cell monocultures (KUSA-A1, n=3; 
MTCT3, n=3) and two specimens per time point of co-culture 
constructs (AM-1/KUSA-A1, n=6; AM-1/ST2, n=6; AM-1/
MTCT3-E1, n=6) were incubated in the inducing condition 
(addition of ascorbic acid and β-glycerophosphate) and 
Alizarin red S (Sigma-Aldrich, Tokyo, Japan) staining was 
performed. Briefly, the harvested cell culture constructs 
were fixed in 10% formalin, embedded in paraffin, cut 
into 10 μm thick sections and subsequently stained with 
Alizarin Red S solution for 5 min. The remaining staining 
dye was washed away with distilled water and sections 
visualized by Olympus BX43 upright microscope equipped 
with a DP27 color camera and CellSens software (all from 
Olympus).
CELL COUNTING
At each time point, the number of cytokeratin- and 
vimentin-positively stained cells was counted at 200× 
magnification from the selection regions in the mono- and 
co-culture constructs. In each section, quantification was 
performed using ImageJ, a Java-based image processing 
program developed at the National Institutes of Health 
for Windows. Relative cell number in both configurations 
was calculated from 5 randomly selected defined regions 
of interest in each case. Results were expressed as means 
+ standard deviation (SD).
STATISTICAL ANALYSIS
All experiments were conducted in duplicates with the 
same passages of the cell lines. Statistical analysis was 
performed using IBM SPSS software version 18.1 (IBM, 
Armonk, NY, USA) for Windows. Data on cell count were 
presented as means + SD. Comparisons between mean 
variables of two groups were performed using the Student 
t test. Level of significance was set as p<0.05.
RESULTS
MORPHOLOGICAL CHARACTERISTICS OF 3D 
MONOCULTURE CELLS
At culture day 3, KUSA/A1 and MC3T3-E1 cells formed 
irregular clusters composed of round and elongated shapes 
(not shown). From culture day 7 to 14, KUSA/A1 cell 
clusters increased in size (Figure 1(A)-1(C)) but MC3T3-E1 
cell aggregates remained relatively dispersive throughout 
the matrix (not shown). ST2 cells were sparsely scattered 
throughout the collagen scaffold and no cell aggregates 
were observed throughout the culture period (not shown). 
AM-1 cell lines, on the other hand, were mainly scattered 
in a dissociated manner as round shapes with occasional 
cluster formation (Figure 1(D)-1(F)).
MORPHOLOGICAL CHARACTERISTICS OF 3D                            
CO-CULTURE CELLS
From culture day 3 onwards, co-culture of AM-1 with KUSA/
A1 cells showed a heterogeneous cell population with 
two distinct morphologies (Figure 2(A)-2(C)). AM-1 cells 
presented as small round to avoid cells with an epithelial 
morphology and these cells were organized into nest-like 
aggregates while the interspersed KUSA/A1 cells were 
identified as elongated spindle-shaped cells with long 
anastomosing cytoplasmic processes (Figure 2(A)-2(C)). 
These morphological alterations were not seen in both AM-1 
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FIGURE 1. Representative microscopic images of KUSA/A1 and AM-1 monocultures in 3D at different time points - day 3 (A, D), 
day 7 (B, E) and day 14 (C, F) (H&E stain; Original magnification: ×200)
FIGURE 2. Representative microscopic images showing the growth of co-cultures in 3D of different cell density at different time 
points - day 3 (A, D, G), day 7 (B, E, H) and day 14 (C, F, I) (H&E stain; Original magnification: A-I, ×200; Insets A-I, ×400)
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co-cultures with MC3T3-E1 (Figure 2(D)-2(F)) and ST2 
cells (Figure 2(G)-2(I)) throughout the experimental period. 
IMMUNOHISTOCHEMICAL AND IMMUNOFLUORESCENCE 
CHARACTERISTICS OF MONO- AND CO-CULTURE CELLS
Cytokeratin was strongly expressed by AM-1 cells in 
monoculture (not shown) and nest-like aggregates in 3D 
co-culture (Figure 3(A)-3(C)). Vimentin immunoreactivity 
was detected in KUSA/A1 cells in monoculture (not shown) 
and flat elongated spindle-shaped cells in 3D co-culture 
and weak-to-absent in AM-1 cells (Figure 3(D)-3(F)). 
Immunofluorescence dual labelling confirmed round cell 
aggregates as cytokeratin-positive (Figure 4(A), 4(B)) 
and elongated spindle-shaped cells as vimentin-positive 
(Figure 4(A), 4(C)). Both round cell nest-like structures 
and elongated spindle-shaped cells in co-culture strongly 
expressed RANK, mildly for RANKL and OPG (Figure 
5(A)-5(C)).
FIGURE 4. Representative sections of KUSA/A1 and AM-1 co-culture constructs showing immunofluorescent staining for 
cytokeratin (red), vimentin (green) and DAPI (blue) (A-D). Cytokeratin reaction was strong in the membrane and cytoplasm of 
round nest-like structures (A, B). Vimentin expression was strong and predominantly membranous in elongated spindle-shaped 
cells (A, C). Nuclei are counterstained with DAPI (D) (Original magnification: A-D, ×200)
FIGURE 3. Representative immunohistochemical images showing AM-1/KUSA-A1 co-culture construct of cell density at 2.5 × 105/
cell type expressing cytokeratin (A-C) and vimentin (D-F) staining at different time points - day 3 (A, D), day 7 (B, E) 
and day 14 (C, F). The experiments were performed in duplicates. Bar=20 micron
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MINERALIZATION CHARACTERISTICS OF MONO-                  
AND CO-CULTURE CELLS
No visible extracellular matrix mineralization was 
observed in mono- and co-cultures during the first week 
of experiment (Figure 6(A)-6(F)). After culture day 14, 
KUSA/A1 cells in monoculture shown evidence of intense 
extracellular matrix mineralization as confirmed by intense 
Alizarin red S staining (Figure 6(H)), whilst KUSA/A1 
cells in the AM-1 co-culture shown reduced Alizarin Red 
S staining (Figure 6(G)). No visible Alizarin red S staining 
in AM-1 cell monoculture was observed (Figure 6(I)).
CELL COUNT OF MONO- AND CO-CULTURE CELLS
Immunoreactivity scores for cytokeratin, vimentin, RANK, 
RANKL and OPG for KUSA/A1 and AM-1 cells in mono- and 
co-culture constructs at different time points are shown in 
Tables 1 and 2. Both KUSA/A1 and AM-1 in co-cultures 
showed a drop in cell count at day 7 but regained back at 
day 14. At the end of culture period (day 14) both KUSA/
A1 and AM-1 in co-cultures showed a significant increase 
in cell count compared to their monoculture counterparts 
(p<0.05).
DISCUSSION
Unlike human cancers, fewer in vitro studies have 
investigated the role of tumor-stromal interactions on 
tumor properties and its dynamics in ameloblastoma 
(Chantravekin & Koontongkaew 2014; Eriksson et al. 
2016; Fuchigami et al. 2014; Sathi et al. 2009, 2008; 
Takebe et al. 2017). Thus far, it is known that parenchyma-
stromal secreted sFRP-2 is implicated in bone resorption 
(Sathi et al. 2009, 2008). Evidently, interaction between 
ameloblastoma cells and stromal fibroblasts via IL-6 
and IL-8 created a microenvironment conducive for 
ameloblastoma extension (Fuchigami et al. 2014), the 
parenchyma-stromal derived CCN2 induces fibrosis and 
promotes osteoclastogenesis in ameloblastoma (Takebe et 
al. 2017), and that ameloblastoma cells co-cultured with 
osteosarcoma cells led to RANKL upregulation (Eriksson 
et al. 2016). Most of these works were based on two-
dimensional (2D) cell cultures which do not reflect the 
in vivo tumor state (Liu et al. 2016). A most recent study 
utilized a 3D organotypic co-culture model (Eriksson et 
al. 2016). Cells in 2D formats undergo proliferation and 
then de-differentiation, consequently losing their essential 
functions. In contrast, cells grown in 3D culture are 
more physiologically relevant in terms of proliferation, 
differentiation, morphology and cellular functionality 
(Antoni et al. 2015).
 In this study, we established an in vitro 3D co-culture 
system where KUSA/A1 (pre-osteoblastic cell lines), 
MC3T3-E1 (osteoblastic cell lines) and ST2 (stromal cell 
lines) were separately co-seeded with AM-1 (ameloblastoma 
cell lines) (Harada et al. 1998; Umezawa et al. 1992). This 
was fabricated to simulate the ameloblastoma disease 
model aimed at gaining some insights into the interactions 
between ameloblastoma and osteoblasts and relate them 
to the growth and osteoclastogenesis in this neoplasm. To 
achieve this objective, these co-culture systems with the 
cultivated cells suspended in the 3D collagen gel space 
in situ were harvested at specific time-points, and probed 
using immunohistochemistry, dual immunofluorescence 
and mineralization assays. 
 A key finding in the present study was significant 
increase in the number of AM-1 cells in 3D co-cultures 
FIGURE 5. Representative sections of KUSA/A1 and AM-1 co-culture constructs showing immunohistochemical staining for 
RANK, RANKL and osteoprotegerin (OPG) (A-C). RANK reaction was strong in the membrane and cytoplasm of round nest-
like structures and elongated spindle-shaped cells (A), RANKL expression was weak to absent in the cytoplasm of both cell 
types (B), and OPG was weakly expressed in both cell types (C) (Original magnification: A-C, ×200)
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FIGURE 6. Representative sections of KUSA/A1 and AM-1 in mono- and co-culture constructs showing no visible extracellular 
matrix mineralization during first week of experiment (A-F). KUSA/A1 cell cultured in 3D at day 14 shows intense Alizarin red 
S staining evidence of diffuse mineralization (H). However, co-culture construct shows reduced mineralization (G). No visible 
Alizarin red S staining in AM-1 cell monoculture was observed throughout experiment (Original magnification: A-I, ×100)
TABLE 1. Immunoreactivity scores for cytokeratin, vimentin, RANK, RANKL and osteoprotegerin (OPG)
Factors Monoculture cell lines Co-culture cell lines
KUSA/A1 AM-1 KUSA/A1 AM-1
Cytokeratin - +++ - ++++
Vimentin +++ - +++ -
RANK + + +++ +++
RANKL + + + +
OPG - - + +
–, no positive cell; +, <25% of cells positive; ++, 25% to 50% of cells positive; +++, >50% of cells positive
TABLE 2. Statistical analysis of mean + SD cell count at different time points for KUSA/A1 
and AM-1 cell lines in 3D mono- and co-cultures
Period 
(day)
KUSA/A1, mean +SD (range) p-value AM-1, mean +SD (range) p-value
n Monoculture n Co-culture n Monoculture n Co-culture
3 1 137.2 ± 36.27 2 163.8 ± 56.62 0.0536 1 117.6 ± 44.91 2 206.2 ± 76.92 0.0629
7 1 186.2 ± 98.15 2 135.8 ± 35.85 0.0148 1 172.6 ± 49.13 2 135.8 ± 77.55 0.0046
14 1 243.8 ± 100.59 2 256 ± 237.41 0.0319 1 63.2 ± 52.3 2 229 ± 118.62 0.0161
n, number of samples; Bold values indicate statistical significance. p<0.05
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compared to their monocultures. In contrast, cell count 
between co-culture and monoculture for KUSA/A1, 
MC3T3-E1 and ST2 was less distinctive at the end of the 
experiment. These observations imply that ameloblastoma-
osteoblastic interactions may have a promotive effect 
on tumor cell growth and growth inhibitory effect 
on osteoblasts. The specific mechanism underlying 
this heterotypic interaction that stimulates tumor cell 
proliferation is unclear. It is known that AM-1 cells show 
downregulation of osteogenic genes including functional 
inactivation for WDR5, a factor which is essential for 
osteoblast differentiation (Sathi et al. 2012). In osteoblastic 
metastases, cancer cell produces osteoblast-stimulating 
factors to induce osteoblastogenesis and the activated 
osteoblasts in turn secrete factors to promote cancer 
colonization and growth (Ottewell 2016). Whether the 
latter signaling pathway occurs in ameloblastoma requires 
further investigation.
 In the original work by Harada et al. (1998), primary 
culture AM-1 cells were described as predominantly 
closely-packed small and polygonal cells with an epithelial 
morphology. In the current study, AM-1 cells co-cultured 
with KUSA/A1 formed visible nest-like epithelial structures 
resembling ameloblastoma cells in their native state whilst 
KUSA/A1 remained as flat, elongated spindle-shaped 
cells. We interpreted this to mean that tumor-osteoblastic 
interactions induce morphodifferentiation of AM-1 cells 
but preservation of KUSA/A1 mesenchymal phenotype. The 
other notable observation was in the co-culture state, both 
cell types were in close proximity with each other. KUSA/
A1 cells with their long cytoplasmic processes interspersed 
and encircled AM-1 nest-like aggregates suggesting 
heterotopic cell-cell interaction. Despite this closeness, 
AM-1 and KUSA/A1 maintained fidelity of their lineages by 
expressing cytokeratin and vimentin, respectively. Lack of 
vimentin positivity in AM-1 cells further indicates absence 
of epithelial-to mesenchymal transition and phenotypic 
switching (Siar & Ng 2014). It is known that intercellular 
communication between cancer and surrounding stromal 
cells creates a local microenvironment that promotes tumor 
survival and growth (Wendler et al. 2016). However, this 
feature of topographic closeness was not observed in 
AM-1 cells co-cultured with either MC3T3-E1 or ST2 cell 
lines. Emerging evidence suggests that differences in cell 
properties and genetic instability may be major reasons 
influencing interaction between these cells (Fong et al. 
2016; Kim & Othmer 2013; Liu et al. 2016).
 In this study, a two-prong approach was used to 
assess local bone metabolism in the 3D co-culture system. 
Firstly, we examined KUSA/A1 and AM-1 in the co-culture 
construct for expression of bone remodeling molecules 
RANK, RANKL and OPG. A RANK-high, RANKL-low and 
OPG-low immunoprofile displayed by both cell types 
suggested a deregulated osteoclastogenesis. Osteoclasts 
are the cells responsible for bone resorption and the 
process of osteoclastogenesis is regulated by the complex 
RANK-RANKL-OPG pathway (Khosla 2001; Proff & Romer 
2009). Binding of RANKL to RANK triggers differentiation 
and activation of pro-osteoclasts (osteoclastic precursor 
cells) to mature (active) osteoclasts (Proff & Romer 
2009). This RANKL-RANK interaction is inhibited by OPG, 
a soluble decoy receptor for RANKL, resulting in osteoclast 
inactivation. Our results differed from previous in vitro 
studies where a 700-fold increase in RANKL was detected 
in co-culture of AM-1 and human osteosarcoma cell 
lines (Eriksson et al. 2016), RANKL and OPG were well-
expressed in AM-1 monoculture (Sandra et al. 2006) and 
in primary ameloblastoma co-cultured with neonatal rabbit 
bone marrow cells (Qian & Huang 2010). The reasons 
for this variability in in vitro findings are unclear. One 
possible explanation may be ascribed to differences in 
cell lines, and types of cell culture system used (Eriksson 
et al. 2016). Other factors that might contribute to these 
disparities in findings include differences in the antibody 
sources used, methods related to tissue processing and 
histomorphometry. In clinicopathological studies, reports 
on RANK-RANKL-OPG expression levels based on surgical 
materials of ameloblastoma show variations in bone 
remodeling activities between primary and recurrent 
tumors (Andrade et al. 2008; da Silva et al. 2008; de Matos 
et al. 2013; Kumamoto & Ooya 2004; Sandra et al. 2005; 
Siar et al. 2015; Tay et al. 2004; Tekkesin et al. 2011). A 
plausible explanation put forth is that RANKL up- or down-
regulation in ameloblastoma might be reflective of the 
dynamic on-going process associated with tumor-induced 
bone remodeling (Siar et al. 2015). In mineralization 
assays, KUSA/A1 monoculture demonstrated abundant 
Alizarin red S positive mineralized areas whereas this 
was diminished in the co-culture. These observations 
lend further support to our immunohistochemical findings 
which suggests that tumor-osteoblast interaction induces 
an altered local bone metabolism.
 There are two main inherent limitations in this study. 
Firstly, the interspecies differences of these cell lines 
may compromise or confound attempts at relating the 
cellular interaction between ameloblastoma tumor cells 
and osteoblastic cells. The other issue is cell senescence 
which delimits the culture study period to 14 days. In 
view of these setbacks, an improved version of the in vitro 
3D tumor-osteoblast co-culture model with eliminated 
interspecies differences and longer cell culture period is 
recommended to address the biologically appropriate cell-
cell interactions in this neoplasm.
CONCLUSION
In conclusion, we successfully established an in vitro 
3D co-culture system to represent an amelobastoma 
disease model aimed at investigating tumor-osteoblast 
interactions. Our rationale was to gain some insights into 
the biological behavior of this enigmatic neoplasm. Present 
in vitro findings suggest that, ameloblastoma-osteoblast 
interactions might play an important role in modulating 
tumor growth and local bone metabolism.
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